跳至主要内容
临床试验/NCT00512915
NCT00512915已完成4 期

Atriale Vorhofsonde 1699 Mit Sehr Kurzem Bipolabstand Zur Vermeidung Von Far Field Sensing

Abbott Medical Devices10 个研究点 分布在 1 个国家目标入组 204 人开始时间: 2006年12月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
204
试验地点
10
主要终点
Incidence of inappropriate mode switch (documented by stored EGM's) using the atrial lead Tendril 1699T with short post ventricular atrial blanking period (PVAB) compared to standard atrial lead (Tentril 1388 or 1688) with optimised PVAB

研究概览

简要总结

The purpose of this study is to evaluate the possibility to program the shortest possible Post Ventricular Atrial Blanking Period (PVAB) and high sensitivity without getting inappropriate Mode Switch due to Far Field R-Wave sensing when using the new Tendril 1699T lead. Comparison with Tendril 1688T or 1388T with optimized Post Ventricular Atrial Blanking (PVAB).

详细描述

Far-field R-wave sensing (FFS) in the atrial channel of dual chamber pacemakers is a relevant source for inappropriate Mode Switch from the DDD mode to the DDI or VDI mode. Inappropriate loss of atrioventricular synchrony due to false positive Mode Switch is hemodynamically disadvantageous, may induce atrial tachyarrhythmias, can lead to pacemaker syndrome, and impairs the reliability of pacemaker Holter data. The aim of the study is to determine whether the use of a new atrial screw in lead with ultra short tip-ring distance of 1.1 mm (Study Group) eliminates the need for individual adjustment of the postventricular atrial blanking period (PVAB) based on an additional test in the Control Group with standard leads.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Indication for dual chamber pacing
  • •Implantation of an Identity (ADX) DR or Victory or later pacemaker (St. Jude Medical)
  • •Bipolar atrial pacing electrode
  • •Age >= 18 years

排除标准

  • •Persistent / permanent Atrial Arrhythmia
  • •Pacemaker Revision
  • •Pregnancy
  • •Participation in another Study involving active implantable medical devices
  • •Unable to complete follow up
  • •Missing patient informed consent
  • •Cardiac surgery or myocardial infarction within the last 4 weeks
  • •Planned cardiac surgery within 3 months after enrollment

研究组 & 干预措施

1699T (Optisense)

Active Comparator

Implantation of the Optisense Lead 1699T, programming of the shortest possible postventricular atrial blanking period (PVAB)

干预措施: pacemaker implantation (Device)

Standard lead

Active Comparator

Implantation of a standard bipolar atrial pacing lead. Optimization of the postventricular atrial blanking period (PVAB) after implantation.

干预措施: pacemaker implantation (Device)

结局指标

主要结局

Incidence of inappropriate mode switch (documented by stored EGM's) using the atrial lead Tendril 1699T with short post ventricular atrial blanking period (PVAB) compared to standard atrial lead (Tentril 1388 or 1688) with optimised PVAB

时间窗: 1 and 3 months post implantation

次要结局

  • 2:1 lock in of Atrial Flutter(1 and 3 months post implantation)
  • Incidence of inappropriate mode switch in respect to lead position and ventricular stimulation frequency(1 and 3 months post implantation)
  • Atrial Flutter in stored EGM's(1 and 3 months post implantation)

研究者

申办方类型
Industry

研究点 (10)

Loading locations...

相似试验